Advanced search
Publication Cover
Clinical Epidemiology Volume 14, 2022 - Issue
Submit an article Journal homepage
187
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom

Antonio González-Pérez1 Pharmacoepidemiology, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9771-5982View further author information
ORCID Icon,
Yanina Balabanova2 Integrated Evidence Generation, Bayer AG, Berlin, GermanyORCID Iconhttps://orcid.org/0000-0002-5065-4788View further author information
ORCID Icon,
María E Sáez1 Pharmacoepidemiology, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, SpainORCID Iconhttps://orcid.org/0000-0001-9299-2534View further author information
ORCID Icon,
Gunnar Brobert3 Integrated Evidence Generation, Bayer AB, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0002-7446-9851View further author information
ORCID Icon &
Luis A García Rodríguez1 Pharmacoepidemiology, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, SpainORCID Iconhttps://orcid.org/0000-0003-0837-2709View further author information
ORCID Icon
Pages 1281-1291 | Received 27 Jul 2022, Accepted 05 Oct 2022, Published online: 02 Nov 2022

References

  • Virani Salim S, Alonso A, Benjamin Emelia J, et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020;141(9). e139–e596.
  • Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962.
  • January CT, Wann LS, Calkins H, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Circulation. 2019;2019:CIR0000000000000665.
  • Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330–1393.
  • Washam JB, Holmes DN, Thomas LE, et al. Pharmacotherapy for atrial fibrillation in patients with chronic kidney disease: insights from ORBIT-AF. J Am Heart Assoc. 2018;7(18):e008928.
  • Brodsky SV. Anticoagulants and acute kidney injury: clinical and pathology considerations. Kidney Res Clin Pract. 2014;33(4):174–180.
  • Fanikos J, Burnett AE, Mahan CE, Dobesh PP. Renal function considerations for stroke prevention in atrial fibrillation. Am J Med. 2017;130(9):1015–1023.
  • Wheeler DS, Giugliano RP, Rangaswami J. Anticoagulation-related nephropathy. J Thromb Haemost. 2016;14(3):461–467.
  • Yao X, Tangri N, Gersh BJ, et al. Renal outcomes in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2017;70(21):2621–2632.
  • Coleman CI, Kreutz R, Sood N, et al. Rivaroxaban’s impact on renal decline in patients with nonvalvular atrial fibrillation: a Us marketscan claims database analysis. Clin Appl Thromb Hemost. 2019;25:1076029619868535.
  • Bonnemeier H, Kreutz R, Enders D, et al. P4749Renal function worsening in factor-xa inhibitors vs phenprocoumon in patients with non-valvular atrial fibrillation and renal disease - insights from the RELOADED study. Eur Heart J. 2019;40(Supplement_1):ehz745.
  • Hernandez AV, Bradley G, Khan M, et al. Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes. Eur Heart J Qual Care Clin Outcome. 2020;6(4):301–307.
  • Sawhney S, Robinson HA, van der Veer SN, et al. Acute kidney injury in the UK: a replication cohort study of the variation across three regional populations. BMJ Open. 2018;8(6):e019435.
  • THIN. The health improvement network. Available from: https://www.the-health-improvement-network.com/en/. Accessed October 7, 2022.
  • Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251–255.
  • Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16(4):393–401.
  • NHS Digital. Read codes. https://digital.nhs.uk/services/terminology-and-classifications/read-codes
  • Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353–360.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Fine JP, Gray RJA. Proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:446.
  • Harel Z, McArthur E, Jeyakumar N, et al. The risk of acute kidney injury with oral anticoagulants in elderly adults with atrial fibrillation. Clin J Am Soc Nephrol. 2021;16(10):1470–1479.
  • Chan Y-H, Yeh Y-H, Hsieh M-Y, et al. The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: a nationwide cohort study in Taiwan. Int J Cardiol. 2018;265:83–89.
  • Sitticharoenchai P, Takkavatakarn K, Boonyaratavej S, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P. Non-vitamin K antagonist oral anticoagulants provide less adverse renal outcomes than warfarin in non-valvular atrial fibrillation: a systematic review and meta analysis. J Am Heart Assoc. 2021;10:e019609.
  • van Gorp RH, Schurgers LJ. New insights into the pros and cons of the clinical use of Vitamin K antagonists (VKAs) versus direct oral anticoagulants (DOACs). Nutrients. 2015;7(11):9538–9557.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.